Bullous pemphigoid treated with intravenous immunoglobulin

Bullous pemphigoid treated with intravenous immunoglobulin

Bullous pemphigoid (BP) is a blistering autoimmune disease that primarily affects elderly patients who commonly present with comorbidities. Side effects from long-term treatment with conventional cytotoxic and immunosuppressive agents may increase morbidity and mortality in this patient population....

Full description

Saved in:
Bibliographic Details
Main Authors: Papapit Tuchinda, Simon Ritchie, Anthony A. Gaspari
Other Authors: University of Maryland, Baltimore
Format: Article
Published: 2018
Subjects:
Medicine
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/34633
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
id th-mahidol.34633
record_format dspace
spelling th-mahidol.346332018-11-09T09:54:11Z Bullous pemphigoid treated with intravenous immunoglobulin Papapit Tuchinda Simon Ritchie Anthony A. Gaspari University of Maryland, Baltimore Mahidol University Medicine Bullous pemphigoid (BP) is a blistering autoimmune disease that primarily affects elderly patients who commonly present with comorbidities. Side effects from long-term treatment with conventional cytotoxic and immunosuppressive agents may increase morbidity and mortality in this patient population. We present a case of BP in a 78-year-old woman with an active pulmonary Mycobacterium avium-intracellulare complex (MAC) infection that precluded the use of systemic corticosteroids or other immunosuppressants. Our patient was successfully treated with intravenous immunoglobulin (IVIG) monotherapy, which may provide an alternative treatment option for BP patients who are unable to tolerate cytotoxic or immunosuppressive therapies. © Cutis 2014. 2018-11-09T02:54:11Z 2018-11-09T02:54:11Z 2014-01-01 Article Cutis. Vol.93, No.5 (2014), 264-268 00114162 2-s2.0-84900521240 https://repository.li.mahidol.ac.th/handle/123456789/34633 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84900521240&origin=inward
institution Mahidol University
building Mahidol University Library
continent Asia
country Thailand
Thailand
content_provider Mahidol University Library
collection Mahidol University Institutional Repository
topic Medicine
spellingShingle Medicine
Papapit Tuchinda
Simon Ritchie
Anthony A. Gaspari
Bullous pemphigoid treated with intravenous immunoglobulin
description Bullous pemphigoid (BP) is a blistering autoimmune disease that primarily affects elderly patients who commonly present with comorbidities. Side effects from long-term treatment with conventional cytotoxic and immunosuppressive agents may increase morbidity and mortality in this patient population. We present a case of BP in a 78-year-old woman with an active pulmonary Mycobacterium avium-intracellulare complex (MAC) infection that precluded the use of systemic corticosteroids or other immunosuppressants. Our patient was successfully treated with intravenous immunoglobulin (IVIG) monotherapy, which may provide an alternative treatment option for BP patients who are unable to tolerate cytotoxic or immunosuppressive therapies. © Cutis 2014.
author2 University of Maryland, Baltimore
author_facet University of Maryland, Baltimore
Papapit Tuchinda
Simon Ritchie
Anthony A. Gaspari
format Article
author Papapit Tuchinda
Simon Ritchie
Anthony A. Gaspari
author_sort Papapit Tuchinda
title Bullous pemphigoid treated with intravenous immunoglobulin
title_short Bullous pemphigoid treated with intravenous immunoglobulin
title_full Bullous pemphigoid treated with intravenous immunoglobulin
title_fullStr Bullous pemphigoid treated with intravenous immunoglobulin
title_full_unstemmed Bullous pemphigoid treated with intravenous immunoglobulin
title_sort bullous pemphigoid treated with intravenous immunoglobulin
publishDate 2018
url https://repository.li.mahidol.ac.th/handle/123456789/34633
_version_ 1763489519413231616

Similar Items